Synergistic Effects of TW-37 and ABT-263 on Renal Cell Carcinoma Cells
BACKGROUND: Renal cell carcinoma (RCC) is a common urological system malignancy lack of effective therapeutic options. Upregulation of the Bcl-2 proteins was correlated with poor prognosis of RCC, suggesting that BH-3 mimetics may be a promising treatment option. ABT-263 is a BH3 mimetic that posses...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868206/ https://www.ncbi.nlm.nih.gov/pubmed/33568941 http://dx.doi.org/10.2147/CMAR.S265788 |